Top

Published in:

Open Access 01-12-2015 | Research article

Outcomes following the implementation of a quality control campaign to decrease sternal wound infections after coronary artery by-pass grafting

Authors: Rickard P. F. Lindblom, Birgitta Lytsy, Camilla Sandström, Nadjira Ligata, Beata Larsson, Ulrika Ransjö, Christine Leo Swenne

Published in: BMC Cardiovascular Disorders | Issue 1/2015

Abstract

Background

Coronary artery by-pass grafting (CABG) remains the optimal strategy in achieving complete revascularization in patients with complex coronary artery disease. However, sternal wound infections (SWI), especially deep SWI are potentially severe complications to the surgery. At the department of cardiothoracic surgery in Uppsala University Hospital a gradual increase in all types of SWI occurred, which peaked in 2009. This prompted an in-depth revision of the whole surgical process. To monitor the frequency of post-operative infections all patients receive a questionnaire that enquires whether any treatment for wound infection has been carried out.

Methods

All patients operated with isolated CABG between start of 2006 and end of 2012 were included in the study. 1515 of 1642 patients answered and returned the questionnaire (92.3 %). The study period is divided into the time before the intervention program was implemented (2006-early 2010) and the time after the intervention (early 2010- end 2012). To assess whether potential differences in frequency of SWI were a consequence of change in the characteristics of the patient population rather than an effect of the intervention a retrospective assessment of medical records was performed, where multiple of the most known risk factors for developing SWI were studied.

Results

We noticed a clear decrease in the frequency of SWI after the intervention. This was not a consequence of a healthier population.

Conclusions

Our results from implementing the intervention program are positive in that they reduce the number of SWI. As several changes in the perioperative care were introduced simultaneously we cannot deduce which is the most effective.

Available only for authorised users

Garcia S, Sandoval Y, Roukoz H, Adabag S, Canoniero M, Yannopoulos D, et al. Outcomes after Complete versus Incomplete Revascularization of Patients with Multivessel Coronary Artery Disease: A Meta-Analysis of 89,883 Patients Enrolled in Randomized Clinical Trials and Observational Studies. J Am Coll Cardiol. 2013;62(16):1421-31.

Fortuna D, Nicolini F, Guastaroba P, De Palma R, Di Bartolomeo S, Saia F, et al. Coronary artery bypass grafting vs percutaneous coronary intervention in a ‘real-world’ setting: a comparative effectiveness study based on propensity score-matched cohorts. Eur J Cardiothorac Surg. 2013;44(1):e16–24.CrossRefPubMed

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375–84.CrossRefPubMed

Kubota H, Miyata H, Motomura N, Ono M, Takamoto S, Harii K, et al. Deep sternal wound infection after cardiac surgery. J Cardiothorac Surg. 2013;8:132.CrossRefPubMedPubMedCentral

Graf K, Ott E, Vonberg RP, Kuehn C, Schilling T, Haverich A, et al. Surgical site infections--economic consequences for the health care system. Langenbecks Arch Surg. 2011;396(4):453–9.CrossRefPubMed

Swenne CL, Lindholm C, Borowiec J, Carlsson M. Surgical-site infections within 60 days of coronary artery by-pass graft surgery. J Hosp Infect. 2004;57(1):14–24.CrossRefPubMed

Berg TC, Kjorstad KE, Akselsen PE, Seim BE, Lower HL, Stenvik MN, et al. National surveillance of surgical site infections after coronary artery bypass grafting in Norway: incidence and risk factors. Eur J Cardiothorac Surg. 2011;40(6):1291–7.PubMed

Bryan CS, Yarbrough WM. Preventing deep wound infection after coronary artery bypass grafting: a review. Tex Heart Inst J. 2013;40(2):125–39.PubMedPubMedCentral

Borer A, Gilad J, Meydan N, Riesenberg K, Schlaeffer F, Alkan M, et al. Impact of active monitoring of infection control practices on deep sternal infection after open-heart surgery. Ann Thorac Surg. 2001;72(2):515–20.CrossRefPubMed

10.

Haycock C, Laser C, Keuth J, Montefour K, Wilson M, Austin K, et al. Implementing evidence-based practice findings to decrease postoperative sternal wound infections following open heart surgery. J Cardiovasc Nurs. 2005;20(5):299–305.CrossRefPubMed

11.

Batalden P, Splaine M. What will it take to lead the continual improvement and innovation of health care in the twenty-first century? Qual Manag Health Care. 2002;11(1):45–54.CrossRefPubMed

12.

Vincent C, Batalden P, Davidoff F. Multidisciplinary centres for safety and quality improvement: learning from climate change science. BMJ Qual Saf. 2011;20 Suppl 1:i73–78.CrossRefPubMedPubMedCentral

13.

Durkin MJ, Dicks KV, Baker AW, Lewis SS, Moehring RW, Chen LF, et al. Seasonal variation of common surgical site infections: does season matter? Infect Control Hosp Epidemiol. 2015;36(9):1011–6.CrossRefPubMed

14.

Bagian JP, Lee C, Gosbee J, DeRosier J, Stalhandske E, Eldridge N, et al. Developing and deploying a patient safety program in a large health care delivery system: you can’t fix what you don’t know about. Jt Comm J Qual Improv. 2001;27(10):522–32.PubMed

15.

Casha AR, Gauci M, Yang L, Saleh M, Kay PH, Cooper GJ. Fatigue testing median sternotomy closures. Eur J Cardiothorac Surg. 2001;19(3):249–53.CrossRefPubMed

16.

Casha AR, Yang L, Kay PH, Saleh M, Cooper GJ. A biomechanical study of median sternotomy closure techniques. Eur J Cardiothorac Surg. 1999;15(3):365–9.CrossRefPubMed

17.

Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360(5):491–9.CrossRefPubMed

18.

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama 2013. 310(20):2191–2194

19.

Lytsy B, Lindblom RP, Ransjö U, Leo-Swenne CJ .Hygienic interventions to decrease deep sternal wound infections following coronary artery bypass grafting. Hosp Infect. 2015. pii: S0195-6701(15)00343-6. doi:10.1016/j.jhin.2015.08.021.

20.

Salehi Omran A, Karimi A, Ahmadi SH, Davoodi S, Marzban M, Movahedi N, et al. Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality. BMC Infect Dis. 2007;7:112.CrossRefPubMedPubMedCentral

21.

Ang LB, Veloria EN, Evanina EY, Smaldone A. Mediastinitis and blood transfusion in cardiac surgery: a systematic review. Heart Lung. 2012;41(3):255–63.CrossRefPubMed

22.

Omar AS, Salama A, Allam M, Elgohary Y, Mohammed S, Tuli AK, et al. Association of time in blood glucose range with outcomes following cardiac surgery. BMC Anesthesiol. 2015;15(1):14.CrossRefPubMedPubMedCentral

23.

Giakoumidakis K, Eltheni R, Patelarou E, Theologou S, Patris V, Michopanou N, et al. Effects of intensive glycemic control on outcomes of cardiac surgery. Heart Lung. 2013;42(2):146–51.CrossRefPubMed

24.

Braenne I, Reiz B, Medack A, Kleinecke M, Fischer M, Tuna S, et al. Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia. BMC Cardiovasc Disord. 2014;14:108.CrossRefPubMedPubMedCentral

25.

Clemmons DR, Underwood LE, Dickerson RN, Brown RO, Hak LJ, MacPhee RD, et al. Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr. 1985;41(2):191–8.PubMed

26.

Toulon A, Breton L, Taylor KR, Tenenhaus M, Bhavsar D, Lanigan C, et al. A role for human skin-resident T cells in wound healing. J Exp Med. 2009;206(4):743–50.CrossRefPubMedPubMedCentral

27.

Balaji S, LeSaint M, Bhattacharya SS, Moles C, Dhamija Y, Kidd M, et al. Adenoviral-mediated gene transfer of insulin-like growth factor 1 enhances wound healing and induces angiogenesis. J Surg Res. 2014;190(1):367–77.CrossRefPubMedPubMedCentral

28.

Goto H, Gomes CM, Corbett CE, Monteiro HP, Gidlund M. Insulin-like growth factor I is a growth-promoting factor for Leishmania promastigotes and amastigotes. Proc Natl Acad Sci U S A. 1998;95(22):13211–6.CrossRefPubMedPubMedCentral

29.

Schneider HJ, Friedrich N, Klotsche J, Schipf S, Nauck M, Volzke H, et al. Prediction of incident diabetes mellitus by baseline IGF1 levels. Eur J Endocrinol. 2011;164(2):223–9.CrossRefPubMed

30.

Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes. 2001;50(3):637–42.CrossRefPubMed

31.

Meberg A, Schoyen R. Bacterial colonization and neonatal infections. Effects of skin and umbilical disinfection in the nursery. Acta Paediatr Scand. 1985;74(3):366–71.CrossRefPubMed

32.

W-Dahl A, Toksvig-Larsen S. Pin site care in external fixation sodium chloride or chlorhexidine solution as a cleansing agent. Arch Orthop Trauma Surg. 2004;124(8):555–8.CrossRefPubMed

Title: Outcomes following the implementation of a quality control campaign to decrease sternal wound infections after coronary artery by-pass grafting
Authors: Rickard P. F. Lindblom
Birgitta Lytsy
Camilla Sandström
Nadjira Ligata
Beata Larsson
Ulrika Ransjö
Christine Leo Swenne
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: BMC Cardiovascular Disorders / Issue 1/2015
Electronic ISSN: 1471-2261
DOI: https://doi.org/10.1186/s12872-015-0148-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Outcomes following the implementation of a quality control campaign to decrease sternal wound infections after coronary artery by-pass grafting

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Renal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study

Abdominal aortic peripheral intervention to facilitate intra-aortic balloon pump support during high risk percutaneous coronary intervention: a case report

Validation study of GRACE risk scores in indigenous and non-indigenous patients hospitalized with acute coronary syndrome

Performance of Sokolow-Lyon index in detection of echocardiographically diagnosed left ventricular hypertrophy in a normal Eastern German population - results of the CARLA study

The association among MDCT-derived three-dimensional visceral adiposities on cardiac diastology and dyssynchrony in asymptomatic population

Angina at Low heart rate And Risk of imminent Myocardial infarction (the ALARM study): a prospective, observational proof-of-concept study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page